IVW-1001 Ophthalmic Eyelid Wipe 0.2%

DRUG2 trials

Sponsors

IVIEW Therapeutics Inc.

Conditions

Dry EyeDry Eye Disease

Phase 1

IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease

CompletedNCT06400459

IVIEW Therapeutics Inc.Dry Eye Disease

Start: 2024-06-25End: 2024-10-15Updated: 2026-02-12

Phase 2

Phase 2b Controlled Study of Dosing Techniques - Part B

CompletedNCT07161011

IVIEW Therapeutics Inc.Dry Eye

Start: 2025-09-08End: 2025-11-03Updated: 2026-03-27